SFSIG
NVS icon

San Francisco Sentry Investment Group’s Novartis NVS Stock Holding History

San Francisco Sentry Investment Group’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$112K Hold
1,225
– – 0.06% 266
2021
Q1 		$105K Hold
1,225
– – 0.04% 289
2020
Q4 		$116K Hold
1,225
– – 0.05% 259
2020
Q3 		$107K Hold
1,225
– – 0.05% 259
2020
Q2 		$107K Hold
1,225
– – 0.06% 252
2020
Q1 		$101K Sell
1,225
-1,850
-60% -$165K 0.06% 218
2019
Q4 		$291K Buy
3,075
+265
+9% +$23.8K 0.13% 166
2019
Q3 		$244K Hold
2,810
– – 0.11% 177
2019
Q2 		$257K Buy
2,810
+355
+14% +$30K 0.12% 172
2019
Q1 		$212K Sell
2,455
-279
-10% -$22.4K 0.09% 204
2018
Q4 		$210K Hold
2,734
– – 0.1% 177
2018
Q3 		$211K Hold
2,734
– – 0.08% 209
2018
Q2 		$185K Sell
2,734
-1,359
-33% -$93.8K 0.08% 216
2018
Q1 		$297K Sell
4,093
-3,879
-49% -$295K 0.09% 211
2017
Q4 		$600K Buy
7,972
+267
+3% +$20.1K 0.18% 121
2017
Q3 		$593K Buy
7,705
+1,009
+15% +$76.2K 0.2% 119
2017
Q2 		$501K Hold
6,696
– – 0.18% 124
2017
Q1 		$446K Hold
6,696
– – 0.25% 100
2016
Q4 		$437K Hold
6,696
– – 0.25% 97
2016
Q3 		$474K Hold
6,696
– – 0.28% 92
2016
Q2 		$495K Hold
6,696
– – 0.3% 93
2016
Q1 		$434K Hold
6,696
– – 0.26% 100
2015
Q4 		$516K Hold
6,696
– – 0.32% 83
2015
Q3 		$552K Hold
6,696
– – 0.39% 78
2015
Q2 		$590K Hold
6,696
– – 0.35% 81
2015
Q1 		$592K Hold
6,696
– – 0.35% 79
2014
Q4 		$556K Hold
6,696
– – 0.32% 80
2014
Q3 		$565K Hold
6,696
– – 0.28% 87
2014
Q2 		$543K Sell
6,696
-2,288
-25% -$180K 0.26% 91
2014
Q1 		$684K Hold
8,984
– – 0.22% 103
2013
Q4 		$647K Hold
8,984
– – 0.22% 108
2013
Q3 		$618K Hold
8,984
– – 0.23% 102
2013
Q2 		$569K Buy
+8,984
New +$585K 0.2% 104

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

San Francisco Sentry Investment Group's NVS Position: Q2 2021 in Review

San Francisco Sentry Investment Group held its Novartis (NVS) position steady in Q2 2021 at 1,225 shares worth $112K. The position accounts for 0.06% of the portfolio, ranked #266.

San Francisco Sentry Investment Group first reported a position in NVS in Q2 2013 and has held it in 33 quarters since. The position peaked at $684K in Q1 2014. 1,120 funds tracked by Wall St. Rank hold NVS as of Q2 2021.

  • San Francisco Sentry Investment Group held 1,225 shares of Novartis worth $112K as of Q2 2021.
  • San Francisco Sentry Investment Group left its Novartis share count unchanged in Q2 2021.
  • Novartis made up 0.06% of San Francisco Sentry Investment Group's portfolio in Q2 2021, its #266 holding.
  • San Francisco Sentry Investment Group first reported a position in Novartis in Q2 2013 and has held it in 33 quarters since.
  • San Francisco Sentry Investment Group's Novartis position peaked at $684K in Q1 2014.
  • 1,120 funds tracked by Wall St. Rank held Novartis as of Q2 2021.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2021, filed 2 Aug 2021.